TSXV:CLAS.H - Post by User
Comment by
MyKnighton Jan 15, 2020 11:18am
44 Views
Post# 30555585
RE:🚨🚨🚨NO NEW DRUGS IN PIPELINE🚨🚨🚨
RE:🚨🚨🚨NO NEW DRUGS IN PIPELINE🚨🚨🚨 They have Both rights on the patent on the planet.
Now is not the time to diluate revenu.
- First GVHD on the planet(1 Billios a year)
- Then Pain killer to complete against Opiod.(really smart move)(50 Billions a year)
The Treatment of acute and chronic pain has nothing to do with Talent only the GVHD .
So the pain market is only own by Kaly no revenu sharing for this one.
SIMPLY incredible.
People saying they have other drugs are flat out lying to your face. They only have the GVHD drug and can't afford to begin testing on the final patient for the Phase 2 trial. Kalytera stated, "Kalytera has agreed to put its program in treatment of acute and chronic pain on hold, and any further payments and expenses in connection with the pain program, and the maintenance of any associated agreements, are subject to discussions with and the approval of the former shareholders of Talent".